{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:14:58Z","timestamp":1793661298183,"version":"4.5.1"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.mam.2024.101252","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T23:12:42Z","timestamp":1707174762000},"page":"101252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis"],"prefix":"10.1016","volume":"96","author":[{"given":"David","family":"Abraham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Lescoat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Stratton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.mam.2024.101252_bib1","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/rheumatology\/ken370","article-title":"Proteomic analysis of scleroderma lesional skin reveals activated wound healing phenotype of epidermal cell layer","volume":"47","author":"Aden","year":"2008","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.mam.2024.101252_bib2","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1038\/jid.2010.120","article-title":"Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis","volume":"130","author":"Aden","year":"2010","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.mam.2024.101252_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s42255-022-00537-5","article-title":"CAR-based therapies: opportunities for immuno-medicine beyond cancer","volume":"4","author":"Aghajanian","year":"2022","journal-title":"Nat. Metab."},{"issue":"1","key":"10.1016\/j.mam.2024.101252_bib4","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1038\/s41598-017-02621-3","article-title":"Use of patterned collagen coated slides to study normal and scleroderma lung fibroblast migration","volume":"7","author":"Ahmed Abdi","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.mam.2024.101252_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/rheumatology\/28.4.281","article-title":"Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma","volume":"28","author":"Akesson","year":"1989","journal-title":"Br. J. Rheumatol."},{"issue":"1","key":"10.1016\/j.mam.2024.101252_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/23971983221140673","article-title":"Ultrasound and magnetic resonance imaging of hands in systemic sclerosis: a cross-sectional analytical study of prevalence of inflammatory changes in patients with subclinical arthropathy","volume":"8","author":"Babulal Vadher","year":"2023","journal-title":"J Scleroderma Relat Disord"},{"issue":"3","key":"10.1016\/j.mam.2024.101252_bib7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/imcb.12217","article-title":"Efferocytosis capacities of blood monocyte-derived macrophages in systemic sclerosis","volume":"97","author":"Ballerie","year":"2019","journal-title":"Immunol. Cell Biol."},{"issue":"4","key":"10.1016\/j.mam.2024.101252_bib8","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/sj.jid.5701101","article-title":"Increased expression of Wnt2 and SFRP4 in Tsk mouse skin: role of Wnt signaling in altered dermal fibrillin deposition and systemic sclerosis","volume":"128","author":"Bayle","year":"2008","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.mam.2024.101252_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/annrheumdis-2017-211501","article-title":"The histone demethylase Jumonji domain-containing protein 3 (JMJD3) regulates fibroblast activation in systemic sclerosis","volume":"77","author":"Bergmann","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.mam.2024.101252_bib10","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/ard-2023-223952","article-title":"Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells","volume":"82","author":"Bergmann","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.mam.2024.101252_bib11","series-title":"Cell Type-specific Biomarkers of Systemic Sclerosis Disease Severity Capture Cell-Intrinsic and Cell-Extrinsic Circuits","author":"Berkowitz","year":"2023"},{"issue":"SI","key":"10.1016\/j.mam.2024.101252_bib12","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1093\/rheumatology\/keac453","article-title":"Human dermal fibroblast-derived exosomes induce macrophage activation in systemic sclerosis","volume":"62","author":"Bhandari","year":"2023","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.mam.2024.101252_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214202","article-title":"Autoantibodies are present before the clinical diagnosis of systemic sclerosis","volume":"14","author":"Burbelo","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.mam.2024.101252_bib14","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/jid.2012.389","article-title":"Increased KGF expression promotes fibroblast activation in a double paracrine manner resulting in cutaneous fibrosis","volume":"133","author":"Canady","year":"2013","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.mam.2024.101252_bib15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12890-019-0943-2","article-title":"Demographic and clinical predictors of progression and mortality in connective tissue disease-associated interstitial lung disease: a retrospective cohort study","volume":"19","author":"Chan","year":"2019","journal-title":"BMC Pulm. Med."},{"issue":"2","key":"10.1016\/j.mam.2024.101252_bib16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/art.23146","article-title":"Heparan sulfate-dependent ERK activation contributes to the overexpression of fibrotic proteins and enhanced contraction by scleroderma fibroblasts","volume":"58","author":"Chen","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"10103","key":"10.1016\/j.mam.2024.101252_bib17","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.mam.2024.101252_bib18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mvr.2017.05.003","article-title":"Quantitative outcome measures for systemic sclerosis-related Microangiopathy - reliability of image acquisition in Nailfold Capillaroscopy","volume":"113","author":"Dinsdale","year":"2017","journal-title":"Microvasc. Res."},{"issue":"6","key":"10.1016\/j.mam.2024.101252_bib19","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1002\/art.38381","article-title":"Derivation and validation of a prediction rule for two-year mortality in early diffuse cutaneous systemic sclerosis","volume":"66","author":"Domsic","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"6295","key":"10.1016\/j.mam.2024.101252_bib20","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science (New York, N.Y.)"},{"issue":"3","key":"10.1016\/j.mam.2024.101252_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102755","article-title":"Mesenchymal stromal cells for systemic sclerosis treatment","volume":"20","author":"Farge","year":"2021","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"10.1016\/j.mam.2024.101252_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1189\/jlb.0306170","article-title":"S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules","volume":"81","author":"Foell","year":"2007","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.mam.2024.101252_bib23","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/0092-8674(80)90094-X","article-title":"Changes in keratin gene expression during terminal differentiation of the keratinocyte","volume":"19","author":"Fuchs","year":"1980","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.mam.2024.101252_bib24","article-title":"Osteopontin links myeloid activation and disease progression in systemic sclerosis","volume":"1","author":"Gao","year":"2020","journal-title":"Cell Rep Med"},{"issue":"7","key":"10.1016\/j.mam.2024.101252_bib25","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.ajpath.2015.03.019","article-title":"Endothelial to mesenchymal transition contributes to endothelial dysfunction in pulmonary arterial hypertension","volume":"185","author":"Good","year":"2015","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.mam.2024.101252_bib26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.mam.2024.101252_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1089\/wound.2011.0310","article-title":"Fibrocytes in fibrotic diseases and wound healing","volume":"1","author":"Grieb","year":"2012","journal-title":"Adv. Wound Care"},{"issue":"8","key":"10.1016\/j.mam.2024.101252_bib28","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.cell.2022.03.011","article-title":"LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma","volume":"185","author":"Gur","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.mam.2024.101252_bib29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1346-8138.2009.00762.x","article-title":"Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis","volume":"37","author":"Hamaguchi","year":"2010","journal-title":"J. Dermatol."},{"issue":"32","key":"10.1016\/j.mam.2024.101252_bib30","doi-asserted-by":"crossref","first-page":"13247","DOI":"10.1073\/pnas.1110486108","article-title":"Essential role of Stat3 in PI3K-induced oncogenic transformation","volume":"108","author":"Hart","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mam.2024.101252_bib31","series-title":"Methyl Cap Binding Protein 2: a Key Epigenetic Protein in Systemic Sclerosis","author":"Henderson","year":"2018"},{"issue":"6","key":"10.1016\/j.mam.2024.101252_bib32","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/pcmr.12912","article-title":"Dysregulation of CCN3 (NOV) expression in the epidermis of systemic sclerosis patients with pigmentary changes","volume":"33","author":"Henrot","year":"2020","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.mam.2024.101252_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.gde.2022.101968","article-title":"Adipocyte plasticity in tissue regeneration, repair, and disease","volume":"76","author":"Horsley","year":"2022","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"530","key":"10.1016\/j.mam.2024.101252_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax6337","article-title":"Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses","volume":"12","author":"Jaynes","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.mam.2024.101252_bib35","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1172\/JCI39675","article-title":"EMT: when epithelial cells decide to become mesenchymal-like cells","volume":"119","author":"Kalluri","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.mam.2024.101252_bib36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/bbrc.1993.1024","article-title":"Interleukin 1 receptor on fibroblasts from systemic sclerosis patients induces excessive functional responses to interleukin 1 beta","volume":"190","author":"Kawaguchi","year":"1993","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.mam.2024.101252_bib37","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/art.10736","article-title":"Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population","volume":"48","author":"Kawaguchi","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.mam.2024.101252_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103314","article-title":"Differentially expressed genes in systemic sclerosis: towards predictive medicine with new molecular tools for clinicians","volume":"22","author":"Keret","year":"2023","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.mam.2024.101252_bib39","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/annrheumdis-2017-211682","article-title":"Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)","volume":"77","author":"Khanna","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.mam.2024.101252_bib40","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S2213-2600(20)30318-0","article-title":"Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"8","author":"Khanna","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.mam.2024.101252_bib41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/art.41055","article-title":"Abatacept in early diffuse cutaneous systemic sclerosis: results of a phase II investigator-initiated, multicenter, double-blind, randomized, placebo-controlled trial","volume":"72","author":"Khanna","year":"2020","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"10.1016\/j.mam.2024.101252_bib42","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/annrheumdis-2019-216823","article-title":"Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial","volume":"79","author":"Khanna","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.mam.2024.101252_bib43","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/rheumatology\/keab477","article-title":"Oxidative stress-induced senescence mediates inflammatory and fibrotic phenotypes in fibroblasts from systemic sclerosis patients","volume":"61","author":"Kizilay Mancini","year":"2022","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.mam.2024.101252_bib44","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","article-title":"Transforming growth factor beta--at the centre of systemic sclerosis","volume":"10","author":"Lafyatis","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.mam.2024.101252_bib45","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.phrs.2011.01.011","article-title":"The role of endothelin-1 signaling in the fibrosis observed in systemic sclerosis","volume":"63","author":"Leask","year":"2011","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.mam.2024.101252_bib46","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1084\/jem.135.6.1351","article-title":"Connective tissue synthesis by scleroderma skin fibroblasts in cell culture","volume":"135","author":"Leroy","year":"1972","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.mam.2024.101252_bib47","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1172\/JCI107827","article-title":"Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast","volume":"54","author":"LeRoy","year":"1974","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.mam.2024.101252_bib48","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jaad.2018.07.033","article-title":"Association of skin hyperpigmentation disorders with digital ulcers in systemic sclerosis: analysis of a cohort of 239 patients","volume":"80","author":"Leroy","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.mam.2024.101252_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/23971983221129211","article-title":"Very Early Diagnosis of Systemic Sclerosis: deciphering the heterogeneity of systemic sclerosis in the very early stages of the disease","volume":"8","author":"Lescoat","year":"2023","journal-title":"J Scleroderma Relat Disord"},{"issue":"3","key":"10.1016\/j.mam.2024.101252_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030894","article-title":"Distinct properties of human M-CSF and GM-CSF monocyte-derived macrophages to simulate pathological lung conditions in vitro: application to systemic and inflammatory disorders with pulmonary involvement","volume":"19","author":"Lescoat","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2024.101252_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114103","article-title":"Combined anti-fibrotic and anti-inflammatory properties of JAK-inhibitors on macrophages in vitro and in vivo: perspectives for scleroderma-associated interstitial lung disease","volume":"178","author":"Lescoat","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.mam.2024.101252_bib52","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/13543784.2021.1923693","article-title":"New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine","volume":"30","author":"Lescoat","year":"2021","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"6","key":"10.1016\/j.mam.2024.101252_bib53","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/BOR.0000000000000835","article-title":"Contribution of monocytes and macrophages to the pathogenesis of systemic sclerosis: recent insights and therapeutic implications","volume":"33","author":"Lescoat","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"issue":"8","key":"10.1016\/j.mam.2024.101252_bib54","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jamadermatol.2023.1729","article-title":"Cutaneous manifestations, clinical characteristics, and prognosis of patients with systemic sclerosis sine scleroderma: data from the international EUSTAR database","volume":"159","author":"Lescoat","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.mam.2024.101252_bib55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/23971983231181719","article-title":"The long-term course of the Health Assessment Questionnaire in patients with systemic sclerosis","volume":"8","author":"Liem","year":"2023","journal-title":"J Scleroderma Relat Disord"},{"issue":"1","key":"10.1016\/j.mam.2024.101252_bib56","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/art.30074","article-title":"CCN2 is required for bleomycin-induced skin fibrosis in mice","volume":"63","author":"Liu","year":"2011","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.mam.2024.101252_bib57","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/stcltm\/szad010","article-title":"Regulatory B cells contribute to the clinical response after bone marrow-derived mesenchymal stromal cell infusion in patients with systemic sclerosis","volume":"12","author":"Loisel","year":"2023","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.mam.2024.101252_bib58","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.actbio.2022.07.054","article-title":"A reductionist approach to determine the effect of cell-cell contact on human epidermal stem cell differentiation","volume":"150","author":"Louis","year":"2022","journal-title":"Acta Biomater."},{"issue":"10","key":"10.1016\/j.mam.2024.101252_bib59","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.mam.2024.101252_bib60","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1172\/JCI131700","article-title":"Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis","volume":"130","author":"Maehara","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.mam.2024.101252_bib61","first-page":"146","article-title":"Randomised, double-blind, placebo-controlled trial of IL1-trap, rilonacept, in systemic sclerosis. A phase I\/II biomarker trial","volume":"36","author":"Mantero","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"issue":"4","key":"10.1016\/j.mam.2024.101252_bib62","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/art.38990","article-title":"Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors","volume":"67","author":"Marangoni","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"10.1016\/j.mam.2024.101252_bib63","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/art.39477","article-title":"Antifibrotic, antioxidant, and immunomodulatory effects of mesenchymal stem cells in HOCl-induced systemic sclerosis","volume":"68","author":"Maria","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"11","key":"10.1016\/j.mam.2024.101252_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187580","article-title":"Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease","volume":"12","author":"Martyanov","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.mam.2024.101252_bib65","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.40934","article-title":"Senescence signature in skin biopsies from systemic sclerosis patients treated with senolytic therapy: potential predictor of clinical response?","volume":"71","author":"Martyanov","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"11","key":"10.1016\/j.mam.2024.101252_bib66","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/rheumatology\/kex280","article-title":"Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta","volume":"56","author":"McCoy","year":"2017","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.mam.2024.101252_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002696","article-title":"Molecular subsets in the gene expression signatures of scleroderma skin","volume":"3","author":"Milano","year":"2008","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.mam.2024.101252_bib68","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.humimm.2021.03.009","article-title":"Peripheral cells from patients with systemic sclerosis disease co-expressing M1 and M2 monocyte\/macrophage surface markers: relation to the degree of skin involvement","volume":"82","author":"Mohamed","year":"2021","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.mam.2024.101252_bib69","article-title":"Organic solvent exposure and systemic sclerosis: a retrospective cohort study based on the Canadian Scleroderma Research Group registry","author":"Muntyanu","year":"2023","journal-title":"J. Am. Acad. Dermatol.S0190-9622(23)00781-8."},{"issue":"6","key":"10.1016\/j.mam.2024.101252_bib70","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"11","key":"10.1016\/j.mam.2024.101252_bib71","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1038\/jid.2014.253","article-title":"Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9","volume":"134","author":"Nikitorowicz-Buniak","year":"2014","journal-title":"J. Invest. Dermatol."},{"issue":"7","key":"10.1016\/j.mam.2024.101252_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134092","article-title":"Partially evoked epithelial-mesenchymal transition (EMT) is associated with increased TGFbeta signaling within lesional scleroderma skin","volume":"10","author":"Nikitorowicz-Buniak","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.mam.2024.101252_bib73","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/art.41798","article-title":"B cell depletion inhibits fibrosis via suppression of profibrotic macrophage differentiation in a mouse model of systemic sclerosis","volume":"73","author":"Numajiri","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"10.1016\/j.mam.2024.101252_bib74","first-page":"70","article-title":"African American race associated with body image dissatisfaction among patients with systemic sclerosis","volume":"34","author":"Nusbaum","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"issue":"7","key":"10.1016\/j.mam.2024.101252_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072269","article-title":"Alveolar epithelial type II cells as drivers of lung fibrosis in idiopathic pulmonary fibrosis","volume":"21","author":"Parimon","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.mam.2024.101252_bib76","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1093\/rheumatology\/keaa680","article-title":"Epidemiology of systemic sclerosis in the UK: an analysis of the clinical practice research datalink","volume":"60","author":"Pauling","year":"2021","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.mam.2024.101252_bib77","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","article-title":"Scleroderma renal crisis: patient characteristics and long-term outcomes","volume":"100","author":"Penn","year":"2007","journal-title":"QJM"},{"issue":"22","key":"10.1016\/j.mam.2024.101252_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228790","article-title":"The immune functions of keratinocytes in skin wound healing","volume":"21","author":"Piipponen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.mam.2024.101252_bib79","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1002\/1529-0131(199905)42:5<930::AID-ANR11>3.0.CO;2-1","article-title":"Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis","volume":"42","author":"Rajkumar","year":"1999","journal-title":"Arthritis Rheum."},{"issue":"4","key":"10.1016\/j.mam.2024.101252_bib80","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/14728214.2020.1836156","article-title":"Emerging drugs for the treatment of scleroderma: a review of recent phase 2 and 3 trials","volume":"25","author":"Roofeh","year":"2020","journal-title":"Expet Opin. Emerg. Drugs"},{"issue":"7","key":"10.1016\/j.mam.2024.101252_bib81","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/art.41659","article-title":"Dysfunctional keratinocytes increase dermal inflammation in systemic sclerosis: results from studies using tissue-engineered scleroderma epidermis","volume":"73","author":"Russo","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.mam.2024.101252_bib82","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2022-253952","article-title":"Silica associated systemic sclerosis: an occupational health hazard","volume":"16","author":"Shivakumar","year":"2023","journal-title":"BMJ Case Rep."},{"issue":"5","key":"10.1016\/j.mam.2024.101252_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126015","article-title":"A role of myocardin related transcription factor-A (MRTF-A) in scleroderma related fibrosis","volume":"10","author":"Shiwen","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.mam.2024.101252_bib84","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJM199909023411006","article-title":"Cutaneous wound healing","volume":"341","author":"Singer","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.mam.2024.101252_bib85","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/annrheumdis-2019-215894","article-title":"Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile","volume":"79","author":"Skaug","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.mam.2024.101252_bib86","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/wrr.12444","article-title":"Macrophages: a review of their role in wound healing and their therapeutic use","volume":"24","author":"Snyder","year":"2016","journal-title":"Wound Repair Regen."},{"issue":"12","key":"10.1016\/j.mam.2024.101252_bib87","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1136\/annrheumdis-2018-213648","article-title":"Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis","volume":"77","author":"Soldano","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.mam.2024.101252_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rdc.2007.12.001","article-title":"Epidemiology and natural history of systemic sclerosis","volume":"16","author":"Steen","year":"1990","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"1","key":"10.1016\/j.mam.2024.101252_bib89","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"Myeloablative autologous stem-cell transplantation for severe scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.mam.2024.101252_bib90","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13075-022-02915-6","article-title":"Therapeutic effects of adipose-derived mesenchymal stem\/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis","volume":"24","author":"Suzuka","year":"2022","journal-title":"Arthritis Res. Ther."},{"issue":"12","key":"10.1016\/j.mam.2024.101252_bib91","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1365-4362.2000.00110.x","article-title":"Correlation between diffuse pigmentation and keratinocyte-derived endothelin-1 in systemic sclerosis","volume":"39","author":"Tabata","year":"2000","journal-title":"Int. J. Dermatol."},{"issue":"1","key":"10.1016\/j.mam.2024.101252_bib92","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1038\/s41467-021-24607-6","article-title":"Myofibroblast transcriptome indicates SFRP2(hi) fibroblast progenitors in systemic sclerosis skin","volume":"12","author":"Tabib","year":"2021","journal-title":"Nat. Commun."},{"issue":"24","key":"10.1016\/j.mam.2024.101252_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10245820","article-title":"SFRP4 expression is linked to immune-driven fibrotic conditions, correlates with skin and lung fibrosis in SSc and a potential EMT biomarker","volume":"10","author":"Tinazzi","year":"2021","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.mam.2024.101252_bib94","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jid.2017.08.024","article-title":"Therapeutic targeting of TAZ and YAP by dimethyl fumarate in systemic sclerosis fibrosis","volume":"138","author":"Toyama","year":"2018","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.mam.2024.101252_bib95","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/BOR.0000000000000898","article-title":"Role of cellular senescence in the pathogenesis of systemic sclerosis","volume":"34","author":"Tsou","year":"2022","journal-title":"Curr. Opin. Rheumatol."},{"issue":"9883","key":"10.1016\/j.mam.2024.101252_bib96","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/S0140-6736(13)61239-8","article-title":"Autologous HSCT for systemic sclerosis","volume":"381","author":"van Laar","year":"2013","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.mam.2024.101252_bib97","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/039463201102400305","article-title":"Attenuation of expression of extracellular matrix genes with siRNAs to Sparc and Ctgf in skin fibroblasts of CTGF transgenic mice","volume":"24","author":"Wang","year":"2011","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"6","key":"10.1016\/j.mam.2024.101252_bib98","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF01457542","article-title":"Changes in cytokeratin expression in epidermal keratinocytes during wound healing","volume":"103","author":"Watanabe","year":"1995","journal-title":"Histochem. Cell Biol."},{"issue":"6212","key":"10.1016\/j.mam.2024.101252_bib99","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1126\/science.1253734","article-title":"Mammalian skin cell biology: at the interface between laboratory and clinic","volume":"346","author":"Watt","year":"2014","journal-title":"Science (New York, N.Y.)"},{"issue":"4","key":"10.1016\/j.mam.2024.101252_bib100","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0962-8924(01)01955-9","article-title":"Paracrine regulation of keratinocyte proliferation and differentiation","volume":"11","author":"Werner","year":"2001","journal-title":"Trends Cell Biol."},{"issue":"5","key":"10.1016\/j.mam.2024.101252_bib101","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/sj.jid.5700786","article-title":"Keratinocyte-fibroblast interactions in wound healing","volume":"127","author":"Werner","year":"2007","journal-title":"J. Invest. Dermatol."},{"issue":"2","key":"10.1016\/j.mam.2024.101252_bib102","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S2213-2600(18)30007-9","article-title":"Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?","volume":"6","author":"Wolters","year":"2018","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"10.1016\/j.mam.2024.101252_bib103","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/cr.2009.5","article-title":"TGF-beta-induced epithelial to mesenchymal transition","volume":"19","author":"Xu","year":"2009","journal-title":"Cell Res."},{"issue":"2","key":"10.1016\/j.mam.2024.101252_bib104","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/art.41813","article-title":"Expansion of fcgamma receptor IIIa-positive macrophages, ficolin 1-positive monocyte-derived dendritic cells, and plasmacytoid dendritic cells associated with severe skin disease in systemic sclerosis","volume":"74","author":"Xue","year":"2022","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.mam.2024.101252_bib105","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.0022-202X.2003.22121.x","article-title":"Possible role of apoptosis in the pathogenesis of bleomycin-induced scleroderma","volume":"122","author":"Yamamoto","year":"2004","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.mam.2024.101252_bib106","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00109-003-0517-9","article-title":"The role of epithelial-to-mesenchymal transition in renal fibrosis","volume":"82","author":"Zeisberg","year":"2004","journal-title":"J. Mol. Med. (Berl.)"}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299724000116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299724000116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T18:20:40Z","timestamp":1758824440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299724000116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":106,"alternative-id":["S0098299724000116"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2024.101252","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2024.101252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101252"}}